WARREN CONWAY: Open Payments
NPI 1245290717 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 55 payments from 16 companies in 2025. Trend: 2023 $5,006 · 2024 $939 · 2025 $838
Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $318 |
| ABBVIE INC. | 13 | $150 |
| Exact Sciences Corporation | 3 | $57 |
| Lilly USA, LLC | 3 | $53 |
| PFIZER INC. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Lundbeck LLC | 2 | $29 |
| Abbott Laboratories | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
Products named: Wegovy, UBRELVY, Rybelsus, Ozempic, Cologuard Collection Kit, MOUNJARO, REXULTI, QULIPTA.
Industry payments across TX — which companies pay providers there.
